Patient groups in Rheumatoid arthritis identified by deep learning respond differently to biologic or targeted synthetic DMARDs

Cycling of biologic or targeted synthetic disease modifying antirheumatic drugs (b/tsDMARDs) in rheumatoid arthritis (RA) patients due to non-response is a problem preventing and delaying disease control. We aimed to assess and validate treatment response of b/tsDMARDs among clusters of RA patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalweit, Maria, Burden, Andrea M., Boedecker, Joschka, Hügle, Thomas, Burkard, Theresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266686/
https://www.ncbi.nlm.nih.gov/pubmed/37267387
http://dx.doi.org/10.1371/journal.pcbi.1011073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266686/
https://www.ncbi.nlm.nih.gov/pubmed/37267387
http://dx.doi.org/10.1371/journal.pcbi.1011073

Ejemplares similares